{"news_desk": "National", "print_page": null, "subsection_name": null, "section_name": "U.S.", "byline": {"original": "By CLYDE HABERMAN", "person": [{"firstname": "Clyde", "rank": 1, "lastname": "HABERMAN", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "1373", "keywords": [{"rank": "1", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Inventions and Patents", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Gleevec (Drug)", "is_major": "N", "name": "subject"}, {"rank": "6", "value": "Novartis AG", "is_major": "N", "name": "organizations"}, {"rank": "7", "value": "Advertising and Marketing", "is_major": "N", "name": "subject"}], "lead_paragraph": "Tensions inherent to drug pricing pit affordability against the need to recoup investment in research, raising questions about how much of the cost patients should have to bear.", "pub_date": "2016-12-12T00:09:21+0000", "document_type": "article", "source": "The New York Times", "snippet": "Tensions inherent to drug pricing pit affordability against the need to recoup investment in research, raising questions about how much of the cost patients should have to bear....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/12/12/us/12RETRO/12RETRO-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/12/12/us/12RETRO/12RETRO-thumbWide.jpg"}, {"height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/12/12/us/12RETRO/12RETRO-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/12/12/us/12RETRO/12RETRO-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/12/12/us/12RETRO/12RETRO-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/12/12/us/12RETRO/12RETRO-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2016/12/11/us/retro-report-medical-patents-profits.html", "slideshow_credits": null, "blog": [], "_id": "584deab895d0e0392607566e", "headline": {"main": "Lives and Profits in the Balance: The High Stakes of Medical Patents", "content_kicker": "Retro Report"}}